Allscripts (MDRX +12.7%) adds to yesterday's post-session gains following a mixed Q4 report that...

|About: Allscripts Healthcare Solut... (MDRX)|By:, SA News Editor

Allscripts (MDRX +12.7%) adds to yesterday's post-session gains following a mixed Q4 report that missed estimates, but showed solid gains in bookings over the period. Baird called the quarter "horrible," "atrocious" and a "disaster," but Jefferies saw progress in the numbers, adding that a "sizable inpatient cross-sell, and a new inpatient win (both in 1Q13) will give some bulls hope." It raises its price target to $11.50 from $10 on the report.